Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleni Efstathiou

Showing results (81-90 of 150) with videos related to

Pageof 15
Sort By:
Urology|January 25, 2011
Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancerIoannis Mountzios, Evangelos Bournakis, Eleni Efstathiou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic responseCharles J Ryan, Shreya Shah, Eleni Efstathiou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2012
Activation of β-catenin signaling in androgen receptor-negative prostate cancer cellsXinhai Wan, Jie Liu, Jing-Fang Lu, et al.
The American Journal of Pathology|January 17, 2012
Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancerKanishka Sircar, Heng Huang, Limei Hu, et al.
Cancer Research Communications|November 6, 2023
Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate CancerEmanuela Gentile, Andrew W Hahn, Jian H Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2011
Modeling a lethal prostate cancer variant with small-cell carcinoma featuresVassiliki Tzelepi, Jiexin Zhang, Jing-Fang Lu, et al.
Cancer Medicine|May 5, 2022
Clinical outcomes and patterns of population-based management of urachal carcinoma of the bladder: An analysis of the National Cancer DatabaseFurkan Dursun, Kelvin Lim, Robert S Svatek, et al.
European Urology|September 24, 2024
Patient-reported Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1/2 Gene Alterations: Final Analysis from the Randomized Phase 3 MAGNITUDE TrialDana E Rathkopf, Guilhem Roubaud, Kim N Chi, et al.
JCI Insight|November 4, 2025
Chromosomal instability in circulating tumor cells and cabazitaxel resistance in metastatic castration-resistant prostate cancerOssian Longoria, Jan Rekowski, Santosh Gupta, et al.
Molecular Imaging and Biology|May 12, 2018
Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In VivoNiki Zacharias, Jaehyuk Lee, Sumankalai Ramachandran, et al.
Pageof 15

Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
Urology|January 25, 2011
Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancerIoannis Mountzios, Evangelos Bournakis, Eleni Efstathiou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic responseCharles J Ryan, Shreya Shah, Eleni Efstathiou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2012
Activation of β-catenin signaling in androgen receptor-negative prostate cancer cellsXinhai Wan, Jie Liu, Jing-Fang Lu, et al.
The American Journal of Pathology|January 17, 2012
Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancerKanishka Sircar, Heng Huang, Limei Hu, et al.
Cancer Research Communications|November 6, 2023
Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate CancerEmanuela Gentile, Andrew W Hahn, Jian H Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2011
Modeling a lethal prostate cancer variant with small-cell carcinoma featuresVassiliki Tzelepi, Jiexin Zhang, Jing-Fang Lu, et al.
Cancer Medicine|May 5, 2022
Clinical outcomes and patterns of population-based management of urachal carcinoma of the bladder: An analysis of the National Cancer DatabaseFurkan Dursun, Kelvin Lim, Robert S Svatek, et al.
European Urology|September 24, 2024
Patient-reported Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1/2 Gene Alterations: Final Analysis from the Randomized Phase 3 MAGNITUDE TrialDana E Rathkopf, Guilhem Roubaud, Kim N Chi, et al.
JCI Insight|November 4, 2025
Chromosomal instability in circulating tumor cells and cabazitaxel resistance in metastatic castration-resistant prostate cancerOssian Longoria, Jan Rekowski, Santosh Gupta, et al.
Molecular Imaging and Biology|May 12, 2018
Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In VivoNiki Zacharias, Jaehyuk Lee, Sumankalai Ramachandran, et al.
Pageof 15